The Pharmaceutical Authority of Egypt issued, in a publication on its official website, an important decision to withdraw 3 medicines from the pharmaceutical market from pharmacies, within the framework of concern the Authority for the health and safety of citizens, and working to achieve the 2030 Sustainable. Development Objectives to preserve the health and safety of sick people.
The Medicines Authority indicated in its statement that the decision to withdraw these medicines was based on non-compliance with the specifications set by the Medicines Authority laboratories, asking citizens to follow the Authority’s decisions relating to medicines and the removal of fake ones, and if there is any fear or doubt about any medicine, a person must contact the Medicines Authority or the pharmacist It is his responsibility to explain all issues related to medicines, either by calling the hotline on 15301 or on the Authority’s website.
The FDA confirmed that the warnings are specific to the works mentioned in the publications and do not apply to the distribution of these provisions in general.
Remove these medicines from a pharmacy
The Saudi Medicines Authority issued several publications regarding warnings against preparations or containers of unknown origin for some preparations circulating in the market, as follows:
First Circular No. 47 of 2024 regarding batch No. – an epileptic drug, used primarily for the treatment and prevention of epileptic seizures. It works by stabilizing the brain’s electrical activity, which helps reduce the frequency and severity of seizures.
The second circular No. 49 of 2024 warns against batch No. “2211082 – 2307036/CJJ” of the drug “SCARO PLUS CREAM 50GM”, due to the presence of counterfeit packages of the aforementioned type the use for Scaro Plus surface treatment and reduce the appearance of scars and the effects of wounds and burns, and it works to improve the appearance of damaged skin, and contains a combination of active ingredients that promote skin regeneration and hydration.
Third Circular No. 48 of 2024 regarding batch No. 221531A of the drug “Neurimax soft gelatin Capsule” produced by the ChemiPharm Company, which was issued to him because he did not comply with this batch with test- The scales of the medicinal authority supplement is used to support nerve health, strengthen the nervous system, and deal with issues of stress and malnutrition.
2024-10-26 15:18:00
#Fraud. #Medicines #Authority #warns #citizens #types #medicine #pharmacies
